Brief: Kaleido Biosciences Reports Q4 loss Per Share $0.56

Kaleido Biosciences

03/03/2021 12:50

March 3 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.56
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.35 -- REFINITIV IBES
DATA
    * KB295 STUDY IN PATIENTS WITH ULCERATIVE COLITIS REMAINS ON
TRACK
WITH TOPLINE DATA ANTICIPATED MID-YEAR 2021
    * TOPLINE DATA FROM TWO ONGOING COVID-19 STUDIES WITH KB109
EXPECTED IN Q1 2021

Source text for Eikon:  ID:nGNX6b8zLD 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))